P731.F - Medexus Pharmaceuticals Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20183/31/20173/31/20163/31/2015
Total Revenue10,009.1676,207.1393,750.2363,068.683
Cost of Revenue4,967.5412,778.3931,295.999962.821
Gross Profit5,041.6263,428.7462,454.2372,105.862
Operating Expenses
Research Development----
Selling General and Administrative7,862.4376,803.6656,750.5817,063.517
Non Recurring----
Others----
Total Operating Expenses12,844.2729,606.0528,152.3018,101.834
Operating Income or Loss-2,835.105-3,398.913-4,402.065-5,033.151
Income from Continuing Operations
Total Other Income/Expenses Net-647.541,567.0262,102.77134.202
Earnings Before Interest and Taxes-2,835.105-3,398.913-4,402.065-5,033.151
Interest Expense-1,186.675-1,082.294-1,001.046-1,001.046
Income Before Tax-3,482.645-1,831.887-2,299.294-4,998.949
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-3,482.645-1,831.887-2,299.294-4,998.949
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,482.645-1,831.887-2,299.294-4,998.949
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-3,482.645-1,831.887-2,299.294-4,998.949